Cancer-associated fibroblasts-induced remodeling of tumor immune microenvironment via Jagged1 in glioma

Cell Signal. 2024 Mar:115:111016. doi: 10.1016/j.cellsig.2023.111016. Epub 2023 Dec 19.

Abstract

Tumor immunosuppression are prominent characteristics of brain glioma. Current standard modality including surgical resection and chemoradiotherapy do not significantly improve clinical outcomes. Cancer-associated fibroblasts (CAFs) that regard as important stromal cells in tumor microenvironment have been confirmed to play crucial roles in tumor development. However, the effects of CAFs on tumor immunosuppression in glioma are not well expounded. In this study, we report that CAFs contributes to the formation of glioma immunosuppressive microenvironment. Specifically, we found that glioma-derived Jagged1 enhanced the proliferation and PD-L1 expression of CAFs in vitro. Importantly, we discovered that Notch1, c-Myc and PD-L1 expression were significantly increased in high Jagged1-expressing gliomas, moreover, we further confirmed that Notch1 and PD-L1 expression located on the CAFs in glioma tissues. We also found that glioma-derived Jagged1 promotes the increase of tumor-infiltrating macrophages, M2 macrophages and Foxp3 Treg cells, as well as no significance of M1 macrophages and CD8+ T cells, indicating potential immunosuppression. This study opens up novel therapeutic strategies reversing CAF immunosuppression for gliomas.

Keywords: Cancer-associated fibroblasts; Glioma; Jagged1; PD-L1; Tumor microenvironment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • B7-H1 Antigen / metabolism
  • CD8-Positive T-Lymphocytes / metabolism
  • Cancer-Associated Fibroblasts* / metabolism
  • Glioma* / metabolism
  • Humans
  • Jagged-1 Protein* / metabolism
  • Tumor Microenvironment

Substances

  • B7-H1 Antigen
  • Jagged-1 Protein